#Intravascular Catheters Industry

[credenceresearchdotblog]

The Micro Guide Catheters Market is projected to grow from USD 4,315 million in 2024 to USD 7,034.72 million by 2032, reflecting a compound annual growth rate (CAGR) of 6.30%.The global healthcare industry continues to evolve rapidly, driven by advancements in medical technology, growing healthcare expenditure, and the increasing prevalence of chronic diseases. One of the critical components of this industry is the micro guide catheters market, which has seen significant growth over the past few years. These catheters are essential in various minimally invasive procedures, particularly in cardiovascular and neurovascular interventions, where precision and safety are paramount.

Browse the full report at https://www.credenceresearch.com/report/micro-guide-catheters-market

Market Overview

Micro guide catheters are specialized, small-diameter catheters used to navigate complex vascular pathways to deliver therapeutic agents or guide larger catheters to the target site. Their design allows for enhanced maneuverability in intricate anatomical structures, making them indispensable in procedures such as angioplasty, embolization, and stent placement.

As of 2023, the global micro guide catheters market was valued at approximately USD 500 million, with projections indicating a compound annual growth rate (CAGR) of around 7-8% over the next decade. This growth is fueled by several factors, including the rising prevalence of cardiovascular and neurovascular diseases, technological advancements, and an increasing preference for minimally invasive surgeries.

Key Growth Drivers

1. Rising Prevalence of Cardiovascular and Neurovascular Diseases: Cardiovascular diseases (CVDs) remain the leading cause of death globally, accounting for nearly 18 million deaths annually. Similarly, neurovascular diseases, including stroke and aneurysms, pose significant health risks. The growing burden of these diseases has led to a surge in demand for effective treatment options, driving the adoption of micro guide catheters in interventional procedures.

2. Technological Advancements: The development of advanced materials and innovative designs has significantly improved the performance of micro guide catheters. Innovations such as hydrophilic coatings, which reduce friction, and the use of nitinol, a superelastic metal alloy, have enhanced the flexibility, trackability, and safety of these catheters. Additionally, the integration of imaging technologies like intravascular ultrasound (IVUS) with micro guide catheters has enabled more precise navigation and positioning, further boosting their utility in complex procedures.

3. Increasing Preference for Minimally Invasive Surgeries: Minimally invasive surgeries offer numerous advantages over traditional open surgeries, including reduced recovery time, lower risk of complications, and shorter hospital stays. As a result, there has been a growing preference for these procedures among both patients and healthcare providers. Micro guide catheters, which play a crucial role in such surgeries, are thus witnessing increased demand.

4. Aging Population: The global population is aging rapidly, with the number of people aged 65 and older expected to double by 2050. This demographic shift is associated with a higher incidence of chronic conditions such as cardiovascular and neurovascular diseases, leading to a greater need for medical interventions. Consequently, the demand for micro guide catheters is expected to rise in tandem with the aging population.

Regional Market Insights

North America currently dominates the micro guide catheters market, accounting for the largest share due to the high prevalence of cardiovascular diseases, well-established healthcare infrastructure, and the presence of leading medical device companies. Europe follows closely, driven by the growing adoption of minimally invasive procedures and favorable reimbursement policies.

The Asia-Pacific region is anticipated to witness the fastest growth during the forecast period. This can be attributed to the increasing healthcare expenditure, rising awareness about advanced treatment options, and a rapidly expanding elderly population in countries like China, Japan, and India. Additionally, the improving healthcare infrastructure in these regions is expected to provide significant growth opportunities for market players.

Competitive Landscape

The micro guide catheters market is highly competitive, with several global and regional players vying for market share. Key players include Boston Scientific Corporation, Terumo Corporation, Medtronic PLC, Cook Medical, and Asahi Intecc Co., Ltd. These companies are focusing on research and development activities to introduce innovative products and expand their product portfolios.

Strategic collaborations, mergers, and acquisitions are also common strategies adopted by market players to strengthen their market position. For instance, in 2022, Boston Scientific acquired Baylis Medical Company, a move aimed at expanding its electrophysiology and structural heart product portfolio, which includes micro guide catheters.

Future Outlook

The future of the micro guide catheters market looks promising, with continuous advancements in medical technology and the increasing adoption of minimally invasive procedures expected to drive sustained growth. However, challenges such as stringent regulatory requirements and the high cost of advanced micro guide catheters may pose barriers to market expansion.

Key Player Analysis

Covidien AG

Boston Scientific Corporation

Terumo Europe N.V.

Micro Therapeutics Inc.

Volcano Corporation

LuMend Corporation

ASAHI INTECC Company Limited

Lake Region Manufacturing Inc.

Segments:

Based on Product:

Over-the-wire Micro Guide Catheters

Flow-directed Micro Guide Catheters

Based on Application:

Cardiovascular

Neurovascular

Other Applications

Based on End User:

Hospitals/Clinics

Ambulatory Surgical Centers

Based on the Geography:

North America

U.S.

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

South-east Asia

Rest of Asia Pacific

Latin America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of the Middle East and Africa

Browse the full report at https://www.credenceresearch.com/report/micro-guide-catheters-market

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: sales@credenceresearch.com

Website: www.credenceresearch.com

[creativeera]

Clot Management Devices: Clot Management for Improved Treatment of Thromboembolism

The Evolution of Clot Removal Technology Clot formation inside blood vessels that supply the lungs, brain or other vital organs can have life-threatening consequences if not treated promptly and effectively. For decades, pharmacological interventions involving anticoagulant and thrombolytic drugs were the primary treatment approaches. However, these systemic therapies are not always fully successful in dissolving or removing clots, and carry risks of hemorrhage. In the past two decades, medical device technologies for minimally invasive mechanical removal or dissolution of clots have rapidly advanced. These clot management devices have revolutionized the treatment of pulmonary embolism and cerebral venous thrombosis. Catheter-Based Clot Retrieval One of the earliest and most widely used clot extraction approaches involves catheter-delivered retrievable stent designs. These devices utilize a nitinol mesh cylindrical structure that can be collapsed inside a delivery catheter and expanded upon deployment within a clot. Barbera first described use of the Tulip venous filter for retrieval of acute iliofemoral deep vein thrombosis in 1994. Building upon this, devices such as the Retrieval Inferior Vena Cava Filter and Denali Filters were developed specifically for clot capture and removal from larger veins. For pulmonary embolism, retrievable expandable stent designs like the Tulip Vena Cava Filter, Recovery Filter and OptEase Filter allowed for minimally invasive extraction of clots from the pulmonary arteries. A major advancement was the introduction of stent retrievers optimized forremoving thromboembolic occlusions from intracranial blood vessels. The Merci Retriever was among the earliest such devices approved by the FDA in 2004 for mechanical thrombectomy in acute ischemic stroke. Second generation retrievable stents like the Solitaire and Trevo devices featured superior design and deliverability profiles enabling higher recanalization rates. Recent studies support use of stent retrievers as the first-line treatment for large vessel occlusions in the anterior cerebral circulation. Ongoing research aims to expand the utility of Clot Management Devices catether-deployed devices to more distal vessel occlusions. Ultrasound-Accelerated Thrombolysis While pharmacologically-assisted thrombolysis remains a mainstay for selected patients, treatment times can be prolonged. Ultrasound energy has shown promise in accelerating fibrinolysis through mechanical fracture of clot structure and increased uptake of thrombolytic drugs. Devices generating low-frequency, high-intensity ultrasound via an intravascular catheter have been evaluated. Early studies demonstrated the EKOS System's ability to rapidly dissolve pulmonary emboli when infusing alteplase, halving treatment duration versus pharmacological therapy alone. The Sonolysis Thrombolytic Infusion Catheter was developed for treating iliofemoral deep vein thrombosis, administering ultrasound plus alteplase directly within the thrombus. More recently, the EkoSonic Endovascular System received FDA clearance for use in acute massive and submassive pulmonary embolism. Its small-profile ultrasound emitter works in tandem with front-line thrombolytic drugs to rapidly recanalize blood clots. Ongoing research also investigates combining intravascular ultrasound with novel thrombolytic drug formulations like microbubbles or plasminogen activators to potentially enhance and target fibrinolysis. Get more insights on Clot Management Devices

About Author:

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)

[bhushans]

A Brighter Future for Autism Care: Global Intravascular Imaging Market

Join the revolution in medical technology as the intravascular imaging market skyrockets towards unprecedented growth  With a projected worth of USD 387.8 million in 2023, this dynamic sector is poised to reach an impressive USD 656.29 million by 2033.

Experience the power of innovation as the market surges forward at a remarkable Compound Annual Growth Rate (CAGR) of 5.4% during the forecast period from 2023 to 2033. From cutting-edge imaging technologies to groundbreaking medical advancements, the potential for transformative impact is limitless.

Get your PDF Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-9926

Key Highlights:

Advancements in Imaging Technology: Ongoing advancements in intravascular imaging technology, including intravascular ultrasound (IVUS), optical coherence tomography (OCT), and near-infrared spectroscopy (NIRS), are driving market growth and innovation. These imaging modalities provide detailed visualization of blood vessel anatomy, plaque morphology, and tissue composition, enabling precise diagnosis, treatment planning, and intervention guidance in cardiovascular procedures.

Clinical Benefits and Improved Patient Outcomes: Intravascular imaging technologies offer healthcare providers valuable diagnostic information and procedural guidance, leading to improved patient outcomes and reduced procedural complications. By providing real-time visualization of vascular structures and pathology, intravascular imaging facilitates accurate lesion assessment, stent sizing, and optimization of treatment strategies, enhancing the safety and efficacy of cardiovascular interventions.

Expansion of Indications and Applications: The expanding indications and applications of intravascular imaging technologies across a wide range of cardiovascular conditions, including coronary artery disease, peripheral vascular disease, and structural heart disorders, are driving market growth. Advances in catheter design, imaging software, and data analysis algorithms are expanding the utility and versatility of intravascular imaging solutions in clinical practice.

Focus on Minimally Invasive Interventions: The shift towards minimally invasive cardiovascular interventions is driving the demand for intravascular imaging technologies that enable precise lesion characterization and treatment planning. Intravascular imaging-guided procedures such as percutaneous coronary intervention (PCI), intravascular lithotripsy (IVL), and transcatheter valve replacement (TAVR) offer patients safer, more effective alternatives to traditional open surgeries, driving market adoption and growth.

Key Takeaways:

The United States is predicted to reach US$ 700 million by 2033.

The United States is predicted to increase at a 5.6% annual rate.

The intravascular imaging market in the United Kingdom is expected to reach US$400 million by the end of the forecast period.

China’s intravascular imaging industry is anticipated to be worthUS$850 million.

The intravascular imaging market in Japan is expected to develop significantly, reaching US$ 700 million by 2033.

“Due to the increased effectiveness of intravascular imaging methods for the diagnosis of blood vessel disease, broad adoption of intravascular imaging is expected to significantly increase the popularity of intravascular imaging while accelerating intravascular imaging revenue growth,” says an FMI analyst.

Competitive Landscape:

In order to boost their chances of making sales abroad, the top companies in the intravascular imaging market are working to expand the reach of their products. Interregional and international market companies working together, merging and acquiring, and forming partnerships are also anticipated to encourage the growth of the intravascular imaging market share.

Some of the top key players in the intravascular imaging market include Acqiris, NIDEK CO. LTD., AGFA Healthcare, Aculight Carl Zeiss AG, Heidelberg Engineering Inc., Optopol, Sonostar Technologies Co.Ltd., OPKO Health, AlazarTech and others.

Siemens Healthineers implemented Luminos Impulse in September 2021, a fluoroscopy technology with an innovative layout and features shared by high-end fluoroscopy systems such as a seamless imaging chain, complete dose optimization, cybersecurity features, and detector-sharing capabilities for radiography.

Siemens Healthineers unveiled Somatom X.ceed in May 2021, a unique high-resolution, rapid speeds CT (computed tomography) scanner designed specifically for extremely demanding clinical applications where time and precision are critical.

Avinger Inc. announced the entire business launch of their TigereyeTM image-guided chronic total occlusion (CTO) crossing system in January 2021.

Segmentation Analysis of the intravascular imaging Market

By Product Type:

Instruments

Software

By Modality:

Handheld

Trolley Mounted

By End User:

Hospitals

Diagnostic Imaging Centers

Ambulatory Surgical Centers

Long Term Care Centers

Others

By Region:

North America

Latin America

Western Europe

Eastern Europe

South Asia & Pacific

East Asia

The Middle East & Africa

[priyanshisingh]

Intravascular Ultrasound IVUS Devices Market Analysis with Size, Revenue, Growth Drivers and Forecast to 2030

The latest market report published by Credence Research, Inc. “Global Intravascular Ultrasound IVUS Devices Market: Growth, Future Prospects, and Competitive Analysis, 2022 – 2030. The global demand for Intravascular ultrasound IVUS devices was valued at USD 0.9 Billion in 2022 and is expected to reach USD 1.47 Billion in 2030, growing at a CAGR of 7.30% between 2023 and 2030.

The intersection of precision, diagnostic accuracy, and patient care, IVUS devices are making significant strides in improving the way medical professionals assess and treat cardiovascular diseases. In this comprehensive article, we delve into the intricacies of IVUS technology, its applications, benefits, and the transformative impact it is having on the healthcare industry.

Understanding Intravascular Ultrasound (IVUS) Devices-

IVUS Devices

IVUS devices, short for Intravascular Ultrasound devices, are cutting-edge medical tools used to visualize the interior of blood vessels with remarkable precision. These devices employ high-frequency sound waves to create detailed cross-sectional images of blood vessels from the inside. Unlike conventional imaging methods, such as X-rays or angiography, IVUS provides clinicians with a unique, real-time view of arterial walls, plaque buildup, and other structural details, enabling more accurate diagnoses and treatment decisions.

The Technology Behind IVUS

At the heart of IVUS technology is a tiny ultrasound transducer mounted on the tip of a catheter. This catheter is carefully guided into the blood vessel of interest, usually through an artery in the wrist or groin. Once inside, the transducer emits sound waves that bounce off the vessel walls and are then captured, processed, and converted into high-resolution images by a computer. The result is a live, 360-degree view of the vessel's interior, allowing physicians to assess the extent of blockages, vessel diameter, and the composition of arterial plaque.

Browse 245 pages report Intravascular Ultrasound IVUS Devices Market By Modality (Virtual Histology IVUS, iMap IVUS, Integrated Backscatter IVUS) By Product (Consoles, Accessories, Catheters, Guidewires, Others) By End-use (Hospitals, Diagnostic Imaging Centers, Academic & Research Institutes) - Growth, Future Prospects & Competitive Analysis, 2016 – 2030) https://www.credenceresearch.com/report/intravascular-ultrasound-ivus-device-market

Applications of IVUS Devices

Cardiovascular Disease Diagnosis

IVUS devices have become an invaluable tool in diagnosing and managing cardiovascular diseases. By providing unparalleled clarity of the arterial structures, IVUS enables healthcare professionals to detect early signs of atherosclerosis, assess stent placement, and determine the most suitable treatment strategies. This level of precision has significantly improved patient outcomes and reduced the risk of complications during cardiac interventions.

Guiding Interventional Procedures

In addition to diagnostics, IVUS plays a pivotal role in guiding interventional procedures. Whether it's angioplasty, stent placement, or atherectomy, IVUS provides real-time feedback to interventional cardiologists, ensuring optimal device positioning and deployment. This not only enhances the success rates of these procedures but also reduces the risk of complications, ultimately leading to faster patient recovery.

Advantages of IVUS Technology

Unprecedented Clarity

The clarity and detail offered by IVUS images are unmatched by any other imaging modality. This level of precision empowers healthcare providers to make informed decisions, leading to better patient outcomes and a higher standard of care.

Minimized Radiation Exposure

Unlike X-rays and CT scans, IVUS relies on ultrasound waves, eliminating the need for ionizing radiation. This reduces the risk to both patients and healthcare providers and makes IVUS a safer option, especially for those who require repeated imaging.

Enhanced Research Capabilities

IVUS devices have opened new avenues for medical research. Researchers can use IVUS to study disease progression, evaluate the effectiveness of novel therapies, and gain insights into the complex world of vascular biology.

The Future of IVUS Technology

As technology continues to advance, so does the potential of IVUS devices. Future developments may include even higher image resolution, improved catheter design for enhanced maneuverability, and integration with artificial intelligence for automated analysis of IVUS images. These advancements will further solidify IVUS as a cornerstone of modern medical practice.

Conclusion

Intravascular Ultrasound (IVUS) devices have revolutionized the way we diagnose and treat cardiovascular diseases. Their ability to provide unparalleled clarity and precision has elevated the standard of care in the medical field. As we look to the future, it's clear that IVUS technology will continue to play a pivotal role in improving patient outcomes, guiding interventions, and advancing medical research. Embracing IVUS is not just a step forward; it's a leap towards a healthier future.

Why to Buy This Report-

The report provides a qualitative as well as quantitative analysis of the global Intravascular Ultrasound IVUS Devices Market by segments, current trends, drivers, restraints, opportunities, challenges, and market dynamics with the historical period from 2016-2020, the base year- 2021, and the projection period 2022-2028.

The report includes information on the competitive landscape, such as how the market's top competitors operate at the global, regional, and country levels.

Major nations in each region with their import/export statistics

The global Intravascular Ultrasound IVUS Devices Market report also includes the analysis of the market at a global, regional, and country-level along with key market trends, major player analysis, market growth strategies, and key application areas.

Browse Full Report: https://www.credenceresearch.com/report/intravascular-ultrasound-ivus-device-market

Visit: https://www.credenceresearch.com/

Related Report: https://www.credenceresearch.com/report/microfluidic-modulation-spectroscopy-market

 Related Report: https://www.credenceresearch.com/report/mesoporous-silica-nanoparticles-drugs-market

For More Information Browse Our Blog: https://www.linkedin.com/pulse/country-level-analysis-intravascular-ultrasound-ivus-device-dean/

Browse Our Blog: https://www.linkedin.com/pulse/intravascular-ultrasound-ivus-devices-market-analysis-priyanshi-singh

About Us -

Credence Research is a viable intelligence and market research platform that provides quantitative B2B research to more than 10,000 clients worldwide and is built on the Give principle. The company is a market research and consulting firm serving governments, non-legislative associations, non-profit organizations, and various organizations worldwide. We help our clients improve their execution in a lasting way and understand their most imperative objectives. For nearly a century, we’ve built a company well-prepared for this task.

Contact Us:

Office No 3 Second Floor, Abhilasha Bhawan, Pinto Park, Gwalior [M.P] 474005 India

[nitasonwane]

Interventional Cardiology Devices Market Size, Share and Demand 2029

The interventional cardiology devices market refers to the sector of the medical device industry that focuses on devices used in the field of interventional cardiology. Interventional cardiology is a specialized branch of cardiology that involves diagnosing and treating cardiovascular diseases using minimally invasive techniques.

Interventional cardiology devices are designed to perform various procedures inside the blood vessels or heart, with the goal of diagnosing and treating conditions such as coronary artery disease, heart valve disorders, congenital heart defects, and peripheral vascular diseases. These devices are typically used in cardiac catheterization procedures, where a thin, flexible tube called a catheter is inserted into a blood vessel and guided to the heart or other relevant areas.

Some common interventional cardiology devices include:

Coronary Stents: These are small mesh-like devices used to keep narrowed or blocked coronary arteries open. They are often made of metal or a combination of metal and a drug-coated polymer

Catheters: These are thin tubes used for various purposes, such as delivering medications, removing blood clots, or performing angioplasty procedures to open blocked arteries.

Balloon Catheters: These catheters have an inflatable balloon at their tip, which can be inflated to open narrowed or blocked blood vessels. They are commonly used in angioplasty procedures.

Intravascular Ultrasound (IVUS) Systems: These devices use ultrasound technology to generate real-time images of blood vessels from inside the body. They provide detailed information about the vessel's structure and aid in guiding interventions

Embolic Protection Devices: These devices are used to capture and remove debris or blood clots that may dislodge during interventional procedures, preventing them from causing further blockages downstream.

Reduction in Number of Elective Surgeries Impeded Market Growth

The COVID-19 pandemic negatively affected the market in 2020 due to elective surgical procedures across the globe, significantly affecting the global market. According to PLOS, in September 2022, in Michigan, the total PCI procedural volume from March to December 2020 declined by 15.2% compared to 2019. In 2021, all elective and interventional surgeries were conducted in several countries across the globe. Preference for interventional procedures due to non-invasive and infection control among patients is set to propel the market growth.

About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them in addressing various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

[markettrend24]

Global 2022-2028 Intravascular Catheters Industry Trends Survey and Prospects Report

Global 2022-2028 Intravascular Catheters Industry Trends Survey and Prospects Report

Global Intravascular Catheters Market- Size, Share and Market Forecasts 2028 This report focuses on the Global Intravascular Catheters Market trends, future forecasts, growth opportunities, key end-user industries, and market players. The objectives of the study are to present the key developments of the market across the globe. Based on the Intravascular Catheters market development status,…

[neha24blog]

Intravascular Catheters Market Projected To Expand At A CAGR 11.8% For The Forecast Period 2019 To 2025 : Grand View Research Inc.

Intravascular Catheters Market Projected To Expand At A CAGR 11.8% For The Forecast Period 2019 To 2025 : Grand View Research Inc.

San Francisco, 28 February 2020: The Report Intravascular Catheters Market Analysis Report By Product (Short, Integrated/Closed PIVCs), By Application, By End Use (Hospitals, Clinics, ASC, Homecare), By Region, And Segment Forecasts, 2019 – 2025

The global intravascular catheters market size is expected to reach USD 8.8 billion by 2025, according to a new report by Grand View Research, Inc.,…

[bhushans]

Unlocking Potential: How Technology is Transforming the Global Intravascular Imaging Market

The global intravascular imaging market would be valued US$ 387.8 million by 2023. By 2033, the market is probably going to reach US$ 656.29 million. The market is anticipated to grow at a compound annual growth rate (CAGR) of 5.4% from 2023 to 2033.

Intravascular imaging technologies are essential for the diagnosis and treatment of cardiovascular illnesses because they provide important information on the anatomy and physiology of blood vessels to medical professionals. The need for intravascular imaging solutions is anticipated to increase as the prevalence of cardiovascular conditions, including diabetes and hypertension, atherosclerosis, and coronary artery disease, continues to rise globally due to factors like aging populations, sedentary lifestyles, and rising rates of risk factors like these.

Claim Your Exclusive Report Sample Preview: https://www.futuremarketinsights.com/reports/sample/rep-gb-9926

Key Highlights:

Advancements in Imaging Technology: Ongoing advancements in intravascular imaging technology, including intravascular ultrasound (IVUS), optical coherence tomography (OCT), and near-infrared spectroscopy (NIRS), are driving market growth and innovation. These imaging modalities provide detailed visualization of blood vessel anatomy, plaque morphology, and tissue composition, enabling precise diagnosis, treatment planning, and intervention guidance in cardiovascular procedures.

Clinical Benefits and Improved Patient Outcomes: Intravascular imaging technologies offer healthcare providers valuable diagnostic information and procedural guidance, leading to improved patient outcomes and reduced procedural complications. By providing real-time visualization of vascular structures and pathology, intravascular imaging facilitates accurate lesion assessment, stent sizing, and optimization of treatment strategies, enhancing the safety and efficacy of cardiovascular interventions.

Expansion of Indications and Applications: The expanding indications and applications of intravascular imaging technologies across a wide range of cardiovascular conditions, including coronary artery disease, peripheral vascular disease, and structural heart disorders, are driving market growth. Advances in catheter design, imaging software, and data analysis algorithms are expanding the utility and versatility of intravascular imaging solutions in clinical practice.

Focus on Minimally Invasive Interventions: The shift towards minimally invasive cardiovascular interventions is driving the demand for intravascular imaging technologies that enable precise lesion characterization and treatment planning. Intravascular imaging-guided procedures such as percutaneous coronary intervention (PCI), intravascular lithotripsy (IVL), and transcatheter valve replacement (TAVR) offer patients safer, more effective alternatives to traditional open surgeries, driving market adoption and growth.

Key Takeaways:

The United States is predicted to reach US$ 700 million by 2033.

The United States is predicted to increase at a 5.6% annual rate.

The intravascular imaging market in the United Kingdom is expected to reach US$400 million by the end of the forecast period.

China’s intravascular imaging industry is anticipated to be worthUS$850 million.

The intravascular imaging market in Japan is expected to develop significantly, reaching US$ 700 million by 2033.

“Due to the increased effectiveness of intravascular imaging methods for the diagnosis of blood vessel disease, broad adoption of intravascular imaging is expected to significantly increase the popularity of intravascular imaging while accelerating intravascular imaging revenue growth,” says an FMI analyst.

Competitive Landscape:

In order to boost their chances of making sales abroad, the top companies in the intravascular imaging market are working to expand the reach of their products. Interregional and international market companies working together, merging and acquiring, and forming partnerships are also anticipated to encourage the growth of the intravascular imaging market share.

Some of the top key players in the intravascular imaging market include Acqiris, NIDEK CO. LTD., AGFA Healthcare, Aculight Carl Zeiss AG, Heidelberg Engineering Inc., Optopol, Sonostar Technologies Co.Ltd., OPKO Health, AlazarTech and others.

Siemens Healthineers implemented Luminos Impulse in September 2021, a fluoroscopy technology with an innovative layout and features shared by high-end fluoroscopy systems such as a seamless imaging chain, complete dose optimization, cybersecurity features, and detector-sharing capabilities for radiography.

Siemens Healthineers unveiled Somatom X.ceed in May 2021, a unique high-resolution, rapid speeds CT (computed tomography) scanner designed specifically for extremely demanding clinical applications where time and precision are critical.

Avinger Inc. announced the entire business launch of their TigereyeTM image-guided chronic total occlusion (CTO) crossing system in January 2021.

Segmentation Analysis of the intravascular imaging Market

By Product Type:

Instruments

Software

By Modality:

Handheld

Trolley Mounted

By End User:

Hospitals

Diagnostic Imaging Centers

Ambulatory Surgical Centers

Long Term Care Centers

Others

By Region:

North America

Latin America

Western Europe

Eastern Europe

South Asia & Pacific

East Asia

The Middle East & Africa

[checmccc]

Medical Coatings Market Share, Size, Global Industry Analysis, Key Growth Drivers Trends, Segments, Opportunity and Forecast 2027

The global medical coatings market size is expected to reach USD 7,990.0 million by 2027, exhibiting a CAGR of 9.7% during the forecast period. The increasing preference for antimicrobial coatings over disinfectants and other cleaning agents will enable speedy expansion of the market,

Information Source- https://www.fortunebusinessinsights.com/medical-coatings-market-104536

states Fortune Business Insights, in a report, titled “Medical Coatings Market Size, Share & COVID-19 Impact Analysis, By Type (Hydrophilic Coatings, Anti-microbial Coatings, Anti-thrombogenic Coatings, and Others), By Material Type (Fluoropolymer, Silicone, Parylene, Metals, and Others), By Application (Medical Device, Medical Implants, Medical Equipment & Tools, and Others), and Regional Forecast, 2020-2027.” The market size stood at USD 3,690.0 million in 2019.

Furthermore, the utilization of light medical instruments such as balloon angioplasty catheters, intravascular catheters, delivery sheaths, guide wires, and implant delivery systems that can pass through complicated and vulnerable areas of the body, which, in turn, will improve the prospects of the market. Their wide use in cerebrovascular, coronary, and peripheral vascular systems during minimally invasive procedures can promote the growth of the market. Besides, the increasing use of such coatings on medical instruments for cardiac and urinary catheterization operations to reduce time consumption will effectively propel the growth of the market in the forthcoming years.

Emphasis on Value Chain Activities by Industry Players to Fortify Business

Prominent companies are now searching for ways to strategically improve their value chain activities. These initiatives will help companies to cater to the growing global demand, boost productivity, strengthen their sales and market presence, produce new goods and technology, reduce their cost of production and grow their customer base.